AEterna Zentaris

A Eterna Zentaris

Pharmaceuticals, 315 Sigma Dr, Charleston, South Carolina, 29486, United States, 11-50 Employees

zentaris.com

  • facebook
  • twitter
  • LinkedIn

phone no Phone Number: 84********

Who is AETERNA ZENTARIS

Aeterna Zentaris Inc. is a specialty biopharmaceutical company commercializing and developing therapeutics and diagnostic tests. The Companys lead product, MacrilenTM (macimorelin), is th...

Read More

map
  • 315 Sigma Dr, Charleston, South Carolina, 29486, United States Headquarters: 315 Sigma Dr, Charleston, South Carolina, 29486, United States
  • 1990 Date Founded: 1990
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: $1 Million to $5 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Pharmaceuticals

SIC SIC Code: 7389

checked-icon Does something look wrong? Fix it. | View contact records from AETERNA ZENTARIS

AEterna Zentaris Org Chart and Mapping

Employees

Similar Companies to AEterna Zentaris

Editas Medicine

  • 201-500 201-500
  • 10 Million to 25 Million $ 10 Million to 25 Million

Humacyte

  • 51-200 51-200
  • 25 Million to 50 Million $ 25 Million to 50 Million

NextPharma

  • 1001-5000 1001-5000
  • 25 Million to 50 Million $ 25 Million to 50 Million
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding AEterna Zentaris

Answer: AEterna Zentaris's headquarters are located at 315 Sigma Dr, Charleston, South Carolina, 29486, United States

Answer: AEterna Zentaris's phone number is 84********

Answer: AEterna Zentaris's official website is https://zentaris.com

Answer: AEterna Zentaris's revenue is $1 Million to $5 Million

Answer: AEterna Zentaris's SIC: 7389

Answer: AEterna Zentaris has 11-50 employees

Answer: AEterna Zentaris is in Pharmaceuticals

Answer: AEterna Zentaris top competitors include: Editas Medicine , Humacyte , NextPharma

Answer: AEterna Zentaris contact info: Phone number: 84******** Website: https://zentaris.com

Answer: Aeterna Zentaris Inc. is a specialty biopharmaceutical company commercializing and developing therapeutics and diagnostic tests. The Companys lead product, MacrilenTM (macimorelin), is the first and only U.S. FDA and European Commission approved oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD). MacrilenTM is currently marketed in the United States through a license agreement with Novo Nordisk and Aeterna Zentaris receives double-digit royalties on sales. Aeterna Zentaris owns all rights to macimorelin outside of the U.S. and Canada. Aeterna Zentaris is also leveraging the clinical success and compelling safety profile of macimorelin to develop it for the diagnosis of child-onset growth hormone deficiency (CGHD), an area of significant unmet need. The Company is actively pursuing business development opportunities for the commercialization of macimorelin in Europe and the rest of the world, in addition to other non-strategic assets to monetize their value.

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access